Jeffrey A. Meyerhardt

Harvard University — United States

Medicine · Health Sciences

115h-index52.0kcitations1.0kworks4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(280), Genetic factors in colorectal cancer(154), Nutrition and Health in Aging(140), Colorectal Cancer Screening and Detection(114), Vitamin D Research Studies(101)

Publications1.0k total

Metabolomic pattern of ultraprocessed food intake and its association with colorectal cancer risk
Gut·2025
Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer
Cancer Epidemiology Biomarkers & Prevention·2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib
JAMA Oncology·2025Open Access
Supplementary Table S4 from Elevated Resting Heart Rate Is an Independent Risk Factor for Mortality in Patients with Colorectal Cancer: A Retrospective Cohort Study
2025Open Access
Data from Elevated Resting Heart Rate Is an Independent Risk Factor for Mortality in Patients with Colorectal Cancer: A Retrospective Cohort Study
2025Open Access
Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)
ESMO Open·2025Open Access
Supplementary Table S2 from Elevated Resting Heart Rate Is an Independent Risk Factor for Mortality in Patients with Colorectal Cancer: A Retrospective Cohort Study
2025Open Access
Contrastive learning enhances fairness in pathology artificial intelligence systems
Cell Reports Medicine·2025· 1 citedOpen Access
Supplementary Table S1 from Elevated Resting Heart Rate Is an Independent Risk Factor for Mortality in Patients with Colorectal Cancer: A Retrospective Cohort Study
2025Open Access
Supplementary Table S3 from Elevated Resting Heart Rate Is an Independent Risk Factor for Mortality in Patients with Colorectal Cancer: A Retrospective Cohort Study
2025Open Access
Supplementary Table 1 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025Open Access
Supplementary Table 3 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025Open Access
Supplementary Table 5 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025Open Access
Supplementary Table 2 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025Open Access
Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025Open Access
Supplementary Table 6 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer
2025Open Access
Supplementary Table S2 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Figure S2 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Figure S1 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Table S1 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
page 1 of 53Next →

Frequent Co-authors

Charles S. Fuchs(27), Robert J. Mayer(12), Shuji Ogino(12), Al B. Benson(11), Leonard B. Saltz(10), Edward L. Giovannucci(9), Alan P. Venook(8), Donna Niedzwiecki(7), Reiko Nishihara(7), Zhi Rong Qian(7), Kimmie Ng(7), Jonathan A. Nowak(6), Andrew T. Chan(6), Katsuhiko Nosho(6), Peter C. Enzinger(6), Mahmoud M. Al-Hawary(5), Stacey A. Cohen(5), Harry S. Cooper(5), Dustin A. Deming(5), Jean L. Grem(5)